Skype

MethylGene Inc.

Click Here To EMAIL INQUIRY
Contact: Mr. Donald F. Corcoran - President
Web: http://www.methylgene.com
E-Mail:
Address: 7220 Frederick-Banting, Montreal, Quebec H4S 2A1, Canada
Phone: +1-(514)-337-3333 | Map/Directions >>
 
 

Profile: MethylGene Inc. is a clinical stage, biopharmaceutical company. We focus on the discovery, development and supply of novel therapeutics for cancer. Our MGCD265 is an oral, multi-targeted kinase inhibitor targeting the c-Met, Tie-2, Ron, VEGF1, VEGF2 and VEGF3 receptor tyrosine kinases. Our MGCD0103 is an oral, isoform-selective HDAC inhibitor which has been in multiple clinical trials for solid tumors and hematological malignancies. Our MGCD290 is a fungal Hos2 inhibitor used in combination with azoles for fungal infections.

8 Products/Services (Click for related suppliers)  
• Biopharmaceutical Drugs• Clinical Trials• Drug Development
• HDAC Inhibitor• Phase I• Phase II
• Phase III• Phase IV

 Edit or Enhance this Company (143 potential buyers viewed listing,  10 forwarded to manufacturer's website)
Browse Category   |   Alphabetical Products   |   ALL 4,000 Suppliers
HomeBuyAdd FREE ListingAdvertise Biotech CompanyBiotech Portal